These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2426465)

  • 41. Phosphatidylinositol metabolism and polyoma-mediated transformation.
    Kaplan DR; Whitman M; Schaffhausen B; Raptis L; Garcea RL; Pallas D; Roberts TM; Cantley L
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3624-8. PubMed ID: 2424008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector.
    Davidson D; Hassell JA
    J Virol; 1987 Apr; 61(4):1226-39. PubMed ID: 3029418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in polyomavirus middle T antigen affecting tumorigenesis.
    Gelinas C; Schaffhausen B; Bockus B; Ratiarson A; Bastin M
    Virology; 1989 May; 170(1):193-200. PubMed ID: 2470192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of the hamster polyomavirus middle T antigen.
    Courtneidge SA; Goutebroze L; Cartwright A; Heber A; Scherneck S; Feunteun J
    J Virol; 1991 Jun; 65(6):3301-8. PubMed ID: 1709702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Further characterisation of the complex containing middle T antigen and pp60.
    Courtneidge SA
    Curr Top Microbiol Immunol; 1989; 144():121-8. PubMed ID: 2477198
    [No Abstract]   [Full Text] [Related]  

  • 47. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.
    Brewster CE; Glover HR; Dilworth SM
    J Virol; 1997 Jul; 71(7):5512-20. PubMed ID: 9188625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.
    Espino PC; Chou WY; Smith AE; Cheng SH
    Oncogene; 1992 Feb; 7(2):317-22. PubMed ID: 1372400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.
    Cartwright CA; Eckhart W; Simon S; Kaplan PL
    Cell; 1987 Apr; 49(1):83-91. PubMed ID: 3103927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sites.
    Harvey R; Oostra BA; Belsham GJ; Gillett P; Smith AE
    Mol Cell Biol; 1984 Jul; 4(7):1334-42. PubMed ID: 6095063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of pp60c-src protein kinase activity in hamster embryo cells transformed by simian virus 40, human adenoviruses, and bovine papillomavirus 1.
    Amini S; Lewis AM; Israel MA; Butel JS; Bolen JB
    J Virol; 1986 Jan; 57(1):357-61. PubMed ID: 2416954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous overexpression of avian pp60c-src and polyomavirus middle T antigen in mammalian cells.
    Cook DN; Pavloff N; Hassell JA
    J Virol; 1990 May; 64(5):2392-5. PubMed ID: 2157894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphorylation of tyrosine in the carboxyl-terminal tryptic peptide of pp60c-src.
    Laudano AP; Buchanan JM
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):892-6. PubMed ID: 2419902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A.
    Glenn GM; Eckhart W
    J Virol; 1995 Jun; 69(6):3729-36. PubMed ID: 7538175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The expression and properties of polyoma virus middle-T antigen in simian cells.
    Belsham GJ; Ely BK; Smith AE
    Virus Res; 1986 Feb; 4(2):157-77. PubMed ID: 3010597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.
    Yi X; Peterson J; Freund R
    J Virol; 1997 Sep; 71(9):6279-86. PubMed ID: 9261344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen.
    Dilworth SM; Horner VP
    J Virol; 1993 Apr; 67(4):2235-44. PubMed ID: 7680389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex.
    Cheng SH; Espino PC; Marshall J; Harvey R; Smith AE
    Mol Cell Biol; 1990 Oct; 10(10):5569-74. PubMed ID: 1697932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.